ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 22 filers reported holding ANI PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $39,173,000 | -22.5% | 36,000,000 | -12.7% | 2.40% | -6.0% |
| Q2 2019 | $50,569,000 | +10.2% | 41,256,000 | 0.0% | 2.55% | -6.2% |
| Q1 2019 | $45,886,000 | +18.1% | 41,256,000 | +7.5% | 2.72% | +6.0% |
| Q4 2018 | $38,855,000 | -14.7% | 38,381,000 | -9.7% | 2.56% | -6.1% |
| Q3 2018 | $45,559,000 | +34.6% | 42,501,000 | +42.9% | 2.73% | +34.8% |
| Q2 2018 | $33,847,000 | – | 29,751,000 | – | 2.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 37,284 | $42,692,000 | 2.46% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $9,120,000 | 0.79% |
| LINDEN ADVISORS LP | 4,500,000 | $5,156,000 | 0.61% |
| Perceptive Advisors | 7,500,000 | $8,488,000 | 0.51% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,000,000 | $1,144,000 | 0.45% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,211,000 | $17,425,000 | 0.40% |
| Hudson Bay Capital Management LP | 10,500,000 | $12,052,000 | 0.36% |
| Penn Capital Management Company, LLC | 4,977,000 | $5,674,000 | 0.23% |
| Visium Asset Management, LP | 6,500,000 | $7,471,000 | 0.11% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,000,000 | $6,840,000 | 0.09% |